TRICYCLIC DIAZEPINES AS TOCOLYTIC OXYTOCIN RECEPTOR ANTAGONISTS
申请人:Wyeth
公开号:EP1377586A1
公开(公告)日:2004-01-07
US7109193B2
申请人:——
公开号:US7109193B2
公开(公告)日:2006-09-19
[EN] TRICYCLIC DIAZEPINES AS TOCOLYTIC OXYTOCIN RECEPTOR ANTAGONISTS<br/>[FR] DIAZEPINES TRYCYCLIQUES UTILISEES COMME ANTAGONISTES TOCOLYTIQUES DES RECEPTEURS DE L'OXYTOCINE
申请人:WYETH CORP
公开号:WO2002083678A1
公开(公告)日:2002-10-24
This invention provides novel tricyclic diazepine compounds as well as methods and pharmaceutical compositions utilizing these compounds for the treatment and/or prevention and/or suppression of disorders which may be remedied or alleviated by oxytocin antagonist acivity, including treatment of preterm labor, dysmerorrhea, endometritis, and for suppressing labor prior to caesarean delivery. These compounds are also useful in enhancing fertility rates, enhancing survival rates and synchronizing estrus in farm animals; and may be useful in the prevention and treatment of disfunctions of the oxytocin system in the central nervous system including obsessive compulsive disorder (OCD) and neuropsychiatric disorders.